Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Connect Biopharma Holdings (CNTB) Current Leases (2023 - 2025)

Historic Current Leases for Connect Biopharma Holdings (CNTB) over the last 3 years, with Q3 2025 value amounting to $336000.0.

  • Connect Biopharma Holdings' Current Leases changed N/A to $336000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $336000.0, marking a year-over-year change of. This contributed to the annual value of $154000.0 for FY2024, which is 4596.49% down from last year.
  • Latest data reveals that Connect Biopharma Holdings reported Current Leases of $336000.0 as of Q3 2025.
  • In the past 5 years, Connect Biopharma Holdings' Current Leases ranged from a high of $350000.0 in Q2 2025 and a low of $154000.0 during Q4 2024
  • In the last 3 years, Connect Biopharma Holdings' Current Leases had a median value of $336000.0 in 2025 and averaged $294200.0.
  • Data for Connect Biopharma Holdings' Current Leases shows a peak YoY increase of 4596.49% (in 2024) and a maximum YoY decrease of 4596.49% (in 2024) over the last 5 years.
  • Connect Biopharma Holdings' Current Leases (Quarter) stood at $285000.0 in 2023, then plummeted by 45.96% to $154000.0 in 2024, then skyrocketed by 118.18% to $336000.0 in 2025.
  • Its Current Leases was $336000.0 in Q3 2025, compared to $350000.0 in Q2 2025 and $346000.0 in Q1 2025.